Efficient Meningioma Tumor Segmentation Using Ensemble Learning
This work addresses the challenge of accurate and efficient brain tumor segmentation for clinicians and researchers with limited hardware, though it is incremental in combining existing architectures.
The paper tackled the problem of automated meningioma tumor segmentation from MRI scans by proposing an ensemble learning approach, achieving average Dice scores of 77.30%, 76.37%, and 73.9% for Enhancing Tumor, Tumor Core, and Whole Tumor on the BraTS-MEN 2025 dataset.
Meningiomas represent the most prevalent form of primary brain tumors, comprising nearly one-third of all diagnosed cases. Accurate delineation of these tumors from MRI scans is crucial for guiding treatment strategies, yet remains a challenging and time-consuming task in clinical practice. Recent developments in deep learning have accelerated progress in automated tumor segmentation; however, many advanced techniques are hindered by heavy computational demands and long training schedules, making them less accessible for researchers and clinicians working with limited hardware. In this work, we propose a novel ensemble-based segmentation approach that combines three distinct architectures: (1) a baseline SegResNet model, (2) an attention-augmented SegResNet with concatenative skip connections, and (3) a dual-decoder U-Net enhanced with attention-gated skip connections (DDUNet). The ensemble aims to leverage architectural diversity to improve robustness and accuracy while significantly reducing training demands. Each baseline model was trained for only 20 epochs and Evaluated on the BraTS-MEN 2025 dataset. The proposed ensemble model achieved competitive performance, with average Lesion-Wise Dice scores of 77.30%, 76.37% and 73.9% on test dataset for Enhancing Tumor (ET), Tumor Core (TC) and Whole Tumor (WT) respectively. These results highlight the effectiveness of ensemble learning for brain tumor segmentation, even under limited hardware constraints. Our proposed method provides a practical and accessible tool for aiding the diagnosis of meningioma, with potential impact in both clinical and research settings.